-
Diabetes Care: Diabetics with pancreatitis have a higher risk of pancreatic cancer than people with type 2 diabetes
Time of Update: 2020-07-14
Pancreatitis and diabetes are recognized as risk factors for pancreatic cancer So far, however, the study has only looked at the risks associated with them individually A recent study published
-
Cancer Immunol Immunother: New Research Explore dating For Ovarian Cancer
Time of Update: 2020-07-14
Standard treatment (SOC) for patients with ovarian cancer (OC) is plagued by high recurrence rates Several studies have shown that immune system semostally in changing the course of OC patients C
-
Targeting HER2 antibody drug conjugateENHERTU for breast cancer, gets quick review by the European Medicines Agency
Time of Update: 2020-07-14
Daiichi/AstraZeneca, Inc.,an antibody drug conjugate dating her2 ENHERTU (FAM-traszumab deruxtecan-nxki) for the treatment of breast cancer and obtained an accelerated review by the European Drug
-
Mol. Pharmaceutics: Canadian scientists develop new method to deliver cancer drugs accurately to tumors
Time of Update: 2020-07-14
Today, colorectal cancer a common type of cancer, with the highest incidence and fatality rates in the world, with nearly 2 million new cases and nearly 900,000 deaths in 2018 alone In China, the
-
Gynecol Oncol: A Phase II study of eviemos and beva semostina in recurrent ovarian, peritoneal and fallopian tube cancers
Time of Update: 2020-07-14
Recurrent the possibility of , fallopian tube and peritoneal cancer senile cancer sourcing it with traditional therapy is limited Preliminary results from phase I studies of eviemos and bevalo semo
-
Gupon: Angiotensin conversion enzyme inhibitors/angiotensin receptor blockers associated with lower risk of colorectal cancer
Time of Update: 2020-07-14
Whether angiokine -strain conversion enzyme (ACE) inhibitors and angiotensin receptor blockers will alter the risk of colorectal cancer remains debatable In a recent study published in the 's author
-
Clini Cancer Research: Total transcriptomic sequencing analysis of tumor tissue after Hu14.18-IL2 immunotherapy identification of prognostic biomarkers
Time of Update: 2020-07-14
Objective: Richard K Yang et al analyzed the whole transcriptomic sequencing data of tumors in 23 stage III-IV melanoma patients in a pilot trial of the anti-GD2 immunoastic factor hu14.18-IL2 to
-
First anti-PAUF single anti-PBP1510 treatment for pancreatic cancer, awarded the title of orphan drug by the FDA
Time of Update: 2020-07-14
Prestige BioPharma announced that the U.S Food and Drug Administration( FDA ) has awarded orphan drug drugs (ODD) for its -up factor (PAUF) monoclonal antibody PBP1510 for the treatment of pancr
-
A list of recent important research progress on leukemia
Time of Update: 2020-07-14
1 Genetic-transcriptiography analysis identified the key transcription factor as the driver of human red leukemia acute erytic leukemia (AML-M6 or AEL) is a rare invasive blood tumor Previou
-
Professor Cao Wei: Avapritinib Drug-resistant Mutation, GIST Patient Treatment To a New Heights
Time of Update: 2020-07-14
Gastrointestinal mesoplinoma (GIST) is mainly caused by GENE mutations driven by KIT and PDGFRA, and surgery is a fundamental treatment for limited GIST GIST is insensitive to chemotherapy, and Ima
-
Antibody drug conjugate DS-1062 study expanded to treat triple-negative breast cancer patients
Time of Update: 2020-07-14
The First Three announced that its antibody drug Couple (ADC), which targets TROP2, is being evaluated for safety, tolerance and initial efficacy in patients with advanced non-removable or metastati
-
Eur J Cancer: HOXA9 meth-ctDNA acts as biomarker for BRCA mutant ovarian cancer
Time of Update: 2020-07-14
Poly (ADP-ribose) polymerase (PARP) inhibitors have become a new treatment option for BRCA mutations ovarian cancer (OC); Therefore, we studied whether homeobox A9 (HOXA9) promoter methylation in
-
Hematol Oncol: Differential expression of estrogen receptor-alpha in follicle tree cells in patients with level 1-2 and level 3 follicular lymphoma
Time of Update: 2020-07-14
Hormone therapy has been used in patients with estrogen receptor alpha (ER alpha) positive breast cancer Recently, a number of studies have reported on the expression of ER alpha in tumor cells B
-
Nucleotide DNA polymerase inhibitor MIV-818 for liver cancer, awarded orphan drug title by the European Union
Time of Update: 2020-07-14
Medivir AB announced that the European Commission, in accordance with the advice of the European Agency for drug Management (EMA), has granted orphan drug products the designation of MIV-818 for t
-
Hypertension: Review of cohort study: Common hypertension drugs may reduce risk of colorectal cancer
Time of Update: 2020-07-14
Drugs commonly used to treat high blood pressure also reduce the risk of colorectal cancer , according to a new study published July 5 in the Journal of the American Heart Association drugs such
-
Professor Wu Gaosong: Progress in Breast Cancer Surgery and Systemic Treatment
Time of Update: 2020-07-14
Breast cancer is a common and high-risk tumor in Chinese women In recent years, the systematic treatment of breast cancer has made great progress, at the same time, surgical treatment in the treatm
-
China Anti-Cancer Association's latest impact factors in three English-language journals released
Time of Update: 2020-07-14
June 29, 2020, the global professional information and analysis service Corey Weian released the 2019 Journal Report (Journal Reports Citation, or JCR), the China Anti-Cancer Association 3 of the
-
Focusing on the nutritional status of cancer patients: malnutrition seriously affects tumor prognosis
Time of Update: 2020-07-14
Global cancer mortality rates have remained high over the past half century According to the WHO Global Cancer Statistics Report, there were 18.1 million new cases of cancer worldwide and 9.6 millio
-
Roche's PD-L1 monoanti-Tecentriq shows hope in early triple-negative breast cancer
Time of Update: 2020-07-14
Roche's PD-L1 monoantitic Tecentriq (atezolizumab) has been used in conjunction with chemotherapy to improve the treatment of patients with early triple-negative breast cancer (TNBC), offering new
-
Brit J Cancer: Seropositive with Helicobacter pylori and hepatobiliary cancer
Time of Update: 2020-07-14
Studies have shown that Helicobacter pylori may play a role in hepatitis, gallstones and liver and bile tumors In a recent study published in the journal British Journal of Cancer, researchers aimed
